Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
98,214,709
-
Share change
-
+9,040,033
-
Total reported value
-
$413,469,375
-
Put/Call ratio
-
60%
-
Price per share
-
$4.21
-
Number of holders
-
128
-
Value change
-
+$38,206,029
-
Number of buys
-
55
-
Number of sells
-
58
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q1 2017
As of 31 Mar 2017,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,214,709 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, JANUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, BVF INC/IL, NUMERIC INVESTORS LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.